Specialty code 183500000X · San Jose, CA
NPI
1487129433
Since 2018
Specialty
Specialty code 183500000X
Code 183500000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
1663 Branham Ln
San Jose, CA, 95118
Phone (408) 267-4942
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$54K
1,039 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Bianca Khishaveh prescribed most often to Medicare patients was Azithromycin, with 194 prescriptions and refills. In total Bianca Khishaveh wrote 1,039 Medicare prescriptions that cost $54K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2018-10-05.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Azithromycin Generic | 194 | 194 | 189 | $449 |
| Oseltamivir Phosphate Generic | 185 | 185 | 184 | $3,203 |
| Ondansetron Hcl Generic | 181 | 181 | 181 | $870 |
| Atovaquone-Proguanil Hcl Atovaquone/Proguanil Hcl | 145 | 162 | 143 | $12K |
| Loperamide Loperamide Hcl | 88 | 88 | 88 | $293 |
| Typhim Vi Typhoid Vi Polysacch Vaccine | 32 | 32 | 32 | $4,792 |
| Twinrix Hepatitis A And B Vaccine/Pf | 28 | 28 | 26 | $3,941 |
| Ipol Poliomyelitis Vaccine, Killed | 25 | 25 | 25 | $1,571 |
| Ixchiq Chikungunya Vaccine, Live/Pf | 20 | 20 | 20 | $5,617 |
| Dexamethasone Generic | 17 | 17 | 15 | $413 |
| Menquadfi Mening Vac A,c,y,w135,c-Tet/Pf | 16 | 16 | 16 | $2,884 |
| Imovax Rabies Vaccine Rabies Vacc, Human Diploid/Pf | 15 | 15 | Under 11 | $6,398 |
| Acetazolamide Generic | 13 | 13 | 13 | $217 |
| Ixiaro Japanese Encephalitis Vacc/Pf | 12 | 12 | 12 | $3,763 |
Brand drugs: 183 claims; generic drugs: 856 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Bianca Khishaveh were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.